NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/20/2024
Back to search
Official data from USPTO
PHARMATHEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5
Filing date
04/12/2023
Registration date
08/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/20/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/15/2020
First use in commerce
12/15/2020
Drawing code
3
Owner type
03
Owner location
Marousi, Attica, GR
Examiner
POMEROY-MURPHY, KAITLIN I
Law office
N80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized cross with rounded edges and the stylized word "PHARMATHEN" to the right of the design.
Holders and representatives
Holders
Pharmathen SA
Representatives
Bradford C. Craig Blank Rome LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Generic pharmaceutical preparation for the treatment of gout; Generic pharmaceutical preparations acting on the central nervous system; Generic pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Generic pharmaceutical preparations for animal skincare; Generic pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Generic pharmaceutical preparations for ocular or intraocular surgery; Generic pharmaceutical preparations for the treatment of heart rhythm disorders; Generic pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Generic pharmaceutical preparations for the treatment of infectious diseases; Generic pharmaceutical preparations for treating allergic rhinitis and asthma; Generic pharmaceutical preparations for treating diabetes; Generic pharmaceutical preparations for treating skin disorders; Generic pharmaceutical preparations for use in chemotherapy; Generic pharmaceutical preparations for use in dermatology; Generic pharmaceutical preparations for use in urology; Generic pharmaceutical preparations for wounds; Generic pharmaceutical preparationsanticoagulants; Generic pharmaceutical preparationsantidepressants; Generic pharmaceutical preparationsappetite suppressants; Generic pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Generic pharmaceutical preparationsa drug delivery system comprising polymer based oral tablets for the continuous release of a wide variety of therapeutic agents; Preparations for destroying parasites; Preparations for destroying vermin; Sanitary preparations for medical use; Self-adhesive dressings; Veterinary preparationspain relief medication
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2024
GNRT
NON-FINAL ACTION E-MAILED
01/11/2024
CNRT
NON-FINAL ACTION WRITTEN
01/11/2024
DOCK
ASSIGNED TO EXAMINER
01/09/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2023
NWAP
NEW APPLICATION ENTERED
04/15/2023
Continuous trademark protection
Get notified about every new filing that threatens PHARMATHEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.